| |
| |
SPOT ON
|
| |
Deaths associated with HPV-vaccine GARDASIL
|
| |
| |
NEW ON THE MARKET
|
| |
Antiepileptic drug stiripentol (DIACOMIT) for DRAVET-syndrome
|
| |
| |
THERAPY FROM A CRITICAL VIEWPOINT
|
| |
ACCORD-study: strategy of near-normal blood glucose in type 2 diabetes increases mortality
Inhibitor of cholesterol absorption ezetimibe (EZETROL, INEGY): no proven benefit, do not use!
Acute coronary syndrome: rebound after withdrawal of clopidogrel (PLAVIX, ISCOVER)?
|
| |
| |
a-t READERS' QUESTIONS AND COMMENTS
|
| |
Discount-contracts: Association of Statutory Health Insurance Physicians and medical professional association advise boycott
|
| |
| |
IN BRIEF
|
| |
Resistance against oseltamivir (TAMIFLU)
Negative studies with antidepressants unpublished
|
 |
Erlotinib (TARCEVA) for pancreatic cancer?
Rosiglitazone (AVANDIA) crashes
Pharmaceutical industry: advertising budget twice as high as research and development
|
| |
| |
CURRENT ADR NETWORK REPORT
|
| |
Muscle pain and ostealgia due to bisphosphonates
|
| |
| |
SIDE EFFECTS
|
| |
Again: suicidality due to varenicline (CHAMPIX)
Melanoma complicating treatment with natalizumab (TYSABRI) for multiple sclerosis?
Warning against suicidality due to anticonvulsant drugs
|
| |